More strikingly, the sensitivity in distinguishing normal versus mucinous early stage ovarian cancer, utilizing apoA-1, TF and TTR (CA125 excluded), was 95% (specificity 86%; AUC 95%) (Table 4). This evidence concerns the gene MUC16 and ovarian cancer.